Evidence map›Paper›PMID 42805657›Full record

ArticleBMJ open2026

"We were caught sleeping": formulation of national policy to decentralise management of drug-resistant tuberculosis in South Africa - a qualitative policy analysis study.

Mosa Moshabela, Lindy Dickson, Waasila Jassat, Helen Cox, Karina Kielmann, Marian Loveday, John Black, Koleka Mlisana, Mark P Nicol, Alison D Grant

Abstract read
In one paragraph

Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mosa MoshabelaAfrica Health Research Institute, School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
Lindy DicksonDepartment of Pathology, Division of Medical Microbiology, University of Cape Town, Cape Town, South Africa.
Waasila JassatSchool of Public Health, University of the Western Cape, Bellville, South Africa.ORCID http://orcid.org/0000-0003-4279-3056
Helen CoxInstitute of Infectious Disease and Molecular Medicine and Wellcome Centre for Infectious Disease Research in Africa, University of Cape Town, Cape Town, South Africa.ORCID http://orcid.org/0000-0002-6538-7192
Karina KielmannInstitute of Global Health and Development, Queen Margaret University, Edinburgh, UK.
Marian LovedayHIV and other Infectious Diseases Research Unit, South African Medical Research Council, Cape Town, South Africa.ORCID http://orcid.org/0000-0001-9205-9314
John BlackDepartment of Infectious Diseases, Livingstone Hospital, Port Elizabeth, South Africa.
Koleka MlisanaSchool of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa.
Mark P NicolDepartment of Pathology, Division of Medical Microbiology, University of Cape Town, Cape Town, South Africa.ORCID http://orcid.org/0000-0002-1366-4805
Alison D GrantAfrica Health Research Institute, School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa alison.grant@lshtm.ac.uk.ORCID http://orcid.org/0000-0002-2437-5195

Funding

Wellcome Trust
6 · The paper itself

Abstract

objectiveIn response to growing numbers of people with drug-resistant tuberculosis (DR-TB), South Africa was, in 2011, among the first countries to launch a national policy on the decentralisation of DR-TB management, preceding normative guidance from the World Health Organization. The objective was to understand the process of formulation of the South African policy on DR-TB service decentralisation.

designQualitative policy analysis. We reviewed policy-related documents to create a timeline, then conducted in-depth interviews with key individuals who had influence over or insights into the policy formulation process. We used Kingdon's policy analysis framework to examine the convergence of problem, policy and politics streams in agenda-setting to create the window of opportunity for policy adoption.

settingSouth Africa.

participantsPolicy makers, implementers and researchers in three South African provinces and at national level, and international DR-TB experts.

resultsInternational publicity concerning the extensively drug-resistant TB outbreak in Tugela Ferry positioned DR-TB as a public health crisis. The health system lacked capacity to match hospital bed supply in specialised hospitals to the high number of people with DR-TB. Reports of detention against will, victimisation and stigmatisation, and failure to uphold person-centred approaches, sparked a human rights outcry. Tensions between actors favouring 'control-based' approaches with emphasis on centralisation and control of patient treatment and resources, and those favouring 'access-based' approaches that emphasised decentralised care led to a tipping point in the policy process. Centralised, specialised DR-TB approaches were perceived to protect quality of care, but these compromised person-centred care and human rights, and restricted access to DR-TB treatment. Policy actors used lessons from pilot studies of DR-TB decentralisation and HIV programmes to overcome policy stagnation.

conclusionsPolicy makers should monitor demand and supply of specialised services and support evidence-informed policy change before health system pressures make reform unavoidable.

Indexed as

Health PolicyPolicy MakingPoliticsTuberculosis, Multidrug-ResistantHumansPublic HealthQualitative ResearchSouth AfricaHealth policyPublic healthQuality of health careSouth AfricaTuberculosis

Identifiers

PMID42805657
PMCPMC13630063

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.